Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

What Lies Ahead For Vice ETFs?

Published 04/23/2018, 05:36 AM
Updated 07/09/2023, 06:31 AM

Vice ETFs primarily target companies dealing in products seen as vices, such as alcohol, tobacco or marijuana. These ETFs are attractive options for those seeking some diversification in their portfolio by investing in the so-called sin stocks.

The need to form such a category was primarily because of some investors’ inclination toward sustainable investing, which mainly seeks to avoid sin stocks. However, some investors choose such stocks for their attractive return potential.

How to Add Sin Stocks to Your Portfolio?

Investors have multiple ways to gain exposure to the space. Depending on their preference, investors can choose pure play alcohol stocks, tobacco, marijuana stocks or form a diversified portfolio of the entire space. However, owing to high volatility in this space and stringent regulations, it is advisable to go the ETF way to gain exposure to the sector.

With experienced managers handling money, investors will be in a good spot when the sector performs well. When AdvisorShares Vice ETF was launched last September, the fund’s portfolio manager Dan Ahrens said, “We’re not making any kind of moral judgment or statement about what people want to consume with this focus; there’s a strong economic argument for looking at these sectors."

Another positive for this segment’s investors is that these products are somewhat staples. Even when the economy is not performing well, people drink and smoke. As a result, even if the sector takes a beating at the time of a recession, it will outperform other segments of the markets, owing to its demand interdependency.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The alcohol industry has been looking up, with growth surpassing expectations. Volumes for spirits grew 2.6% last year, according to data provided by the Distilled Spirits Council, while supplier revenue was up 4.0% to $26.2 billion. Moreover, the cannabis and legal marijuana industry is seeing strong growth although tobacco sales are seeing a slight decline.

Let us now discuss a few ETFs providing exposure to the space.

Spirited Funds/ETFMG Whiskey & Spirits ETF WSKY

This fund focuses on providing exposure to companies across the world involved in the production and sale of whiskey and spirits. It has AUM of $15.0 million and charges a fee of 60 basis points a year. From a geographical perspective, the fund has high allocation to the United Kingdom, France and United States, with 25.9%, 25.0% and 13.5% exposure, respectively. It has an allocation of 16.9% to Diageo (LON:DGE), 9.0% to Pernod Ricard (PA:PERP) and 5.6% to Radico Khaitan. This fund has garnered $3.3 million in inflows so far this year. It has returned 28.7% in a year.

ETFMG Alternative Harvest ETF (SNX:MJ)

This fund seeks to provide exposure to companies involved in the cannabis business.

It has AUM of $371.9 million and charges a fee of 75 basis points a year. The fund’s top three holdings are GW Pharmaceuticals Plc (NASDAQ:GWPH) , Hydropothecary Corp and Medreleaf Corp, with 6.3%, 6.0% and 5.9% allocation, respectively. This fund has garnered $405.6 million in inflows so far this year. It has returned 3.0% in a year.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

AdvisorShares Vice ETF (WA:ACT)

This fund is a popular ETF focused on providing exposure to companies involved in the alcohol, tobacco or cannabis business.

It has AUM of $15.0 million and charges a fee of 75 basis points a year. From a sector perspective, the fund has 53.0% allocation to alcohol businesses, 26.0% to tobacco businesses and 21.0% to Cannabis businesses. The fund’s top three holdings are AbbVie Inc (NYSE:ABBV) , Constellation Brands Inc A (NYSE:STZ) and MGP Ingredients Inc (NASDAQ:MGPI) , with 1.1%, 0.9% and 0.8% allocation, respectively. This fund has garnered $5.4 million in inflows so far this year. It has lost 0.6% in a year.

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>









AbbVie Inc. (ABBV): Free Stock Analysis Report

Constellation Brands Inc (STZ): Free Stock Analysis Report

ETFMG-WSKY&SPRT (WSKY): ETF Research Reports

MGP Ingredients, Inc. (MGPI): Free Stock Analysis Report

GW Pharmaceuticals PLC (GWPH): Free Stock Analysis Report

ADVSR-VICE ETF (ACT): ETF Research Reports

ETFMG-ALT HRVST (MJ): ETF Research Reports

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.